Candidal bloodstream infection represents a high risk infection, even for immunocompetent patients. Mortality is significant even for IV line-associated candidaemia. Blood cultures are seldom contaminated by fungi and any patient with an isolate must be subjected to careful clinical assessment. Our comment serves to give a few reminders that follow on from the liaison between the Clinical Microbiologist and clinician at the time that the isolate is identified.
Conversely, Candida species isolated from the urine represent a much lower risk situation. Our comment is based on advice provided in the reference below.
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Full text available.
Image from MicrobeOnline.com